Greenleaf Trust’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $821K | Sell |
1,462
-246
| -14% | -$158K | 0.01% | 382 |
|
|
2025
Q4 | $1.16M | Buy |
1,708
+59
| +4% | +$40.2K | 0.01% | 296 |
|
|
2025
Q3 | $1.05M | Buy |
1,649
+49
| +3% | +$29.7K | 0.01% | 315 |
|
|
2025
Q2 | $858K | Sell |
1,600
-191
| -11% | -$91.3K | 0.01% | 354 |
|
|
2025
Q1 | $752K | Buy |
1,791
+163
| +10% | +$70.8K | 0.01% | 392 |
|
|
2024
Q4 | $673K | Sell |
1,628
-102
| -6% | -$44.7K | 0.01% | 435 |
|
|
2024
Q3 | $874K | Sell |
1,730
-50
| -3% | -$24.3K | 0.01% | 368 |
|
|
2024
Q2 | $867K | Sell |
1,780
-103
| -5% | -$51.7K | 0.01% | 329 |
|
|
2024
Q1 | $1.02M | Buy |
1,883
+252
| +15% | +$138K | 0.01% | 299 |
|
|
2023
Q4 | $905K | Sell |
1,631
-35
| -2% | -$16.4K | 0.01% | 309 |
|
|
2023
Q3 | $728K | Sell |
1,666
-1
| -0.1% | -$499 | 0.01% | 331 |
|
|
2023
Q2 | $837K | Sell |
1,667
-83
| -5% | -$39.8K | 0.01% | 321 |
|
|
2023
Q1 | $875K | Buy |
1,750
+51
| +3% | +$24.4K | 0.01% | 311 |
|
|
2022
Q4 | $693K | Buy |
1,699
+481
| +39% | +$187K | 0.01% | 353 |
|
|
2022
Q3 | $397K | Sell |
1,218
-108
| -8% | -$39.7K | 0.01% | 455 |
|
|
2022
Q2 | $465K | Sell |
1,326
-182
| -12% | -$74.2K | 0.01% | 419 |
|
|
2022
Q1 | $825K | Buy |
1,508
+226
| +18% | +$119K | 0.01% | 285 |
|
|
2021
Q4 | $844K | Sell |
1,282
-38
| -3% | -$23.9K | 0.01% | 285 |
|
|
2021
Q3 | $821K | Buy |
1,320
+6
| +0.5% | +$4.03K | 0.01% | 265 |
|
|
2021
Q2 | $830K | Buy |
1,314
+107
| +9% | +$59.1K | 0.01% | 268 |
|
|
2021
Q1 | $591K | Sell |
1,207
-91
| -7% | -$45.6K | 0.01% | 334 |
|
|
2020
Q4 | $649K | Buy |
1,298
+42
| +3% | +$18.8K | 0.01% | 268 |
|
|
2020
Q3 | $494K | Buy |
1,256
+57
| +5% | +$21.1K | 0.01% | 288 |
|
|
2020
Q2 | $396K | Sell |
1,199
-43
| -3% | -$12.4K | 0.01% | 339 |
|
|
2020
Q1 | $301K | Sell |
1,242
-479
| -28% | -$125K | 0.01% | 336 |
|
|
2019
Q4 | $449K | Buy |
1,721
+22
| +1% | +$5.8K | 0.01% | 314 |
|
|
2019
Q3 | $462K | Buy |
1,699
+31
| +2% | +$8.63K | 0.01% | 301 |
|
|
2019
Q2 | $459K | Sell |
1,668
-2,190
| -57% | -$540K | 0.01% | 296 |
|
|
2019
Q1 | $863K | Sell |
3,858
-852
| -18% | -$176K | 0.01% | 178 |
|
|
2018
Q4 | $876K | Buy |
4,710
+628
| +15% | +$129K | 0.02% | 175 |
|
|
2018
Q3 | $1.02M | Buy |
4,082
+353
| +9% | +$85.7K | 0.02% | 172 |
|
|
2018
Q2 | $813K | Buy |
+3,729
| New | +$768K | 0.02% | 187 |
|
|
2017
Q3 | – | Sell |
-1,383
| Closed | -$223K | – | 702 |
|
|
2017
Q2 | $223K | Buy |
+1,383
| New | +$225K | 0.01% | 330 |
|
Other funds holding IDXX
VCM
VPM
Greenleaf Trust's IDXX Position: Q1 2026 in Review
Greenleaf Trust reduced its Idexx Laboratories (IDXX) stake by 14% in Q1 2026, selling an estimated $158K and leaving 1,462 shares worth $821K. The position accounts for 0.01% of the portfolio, ranked #382.
Greenleaf Trust first reported a position in IDXX in Q2 2017 and has held it in 33 quarters since. The position peaked at $1.16M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Greenleaf Trust held 1,462 shares of Idexx Laboratories worth $821K as of Q1 2026.
- Greenleaf Trust sold 246 Idexx Laboratories shares in Q1 2026, an estimated $158K.
- Idexx Laboratories made up 0.01% of Greenleaf Trust's portfolio in Q1 2026, its #382 holding.
- Greenleaf Trust first reported a position in Idexx Laboratories in Q2 2017 and has held it in 33 quarters since.
- Greenleaf Trust's Idexx Laboratories position peaked at $1.16M in Q4 2025.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Greenleaf Trust's 13F filing for Q1 2026, filed 27 Apr 2026.